Did you not read? Why would Point 72 have purchased short at $1.34 with alot more shares as warrants to be exercised at $1.25 after 6 months, right before Oncosec's next major catalyst, the one Merck assisted in. Coincidence? That the same was done with CPXX. By next summer the price will be over five and those shares will quickly be exercised to then profit on the run and afterwards they can do whatever they want with them. So as a savvy investor what should I be doing?
I hope you were savvy enough to buy when I told you to buy and followed what a known hedge fund was doing, buying while the price was on the bottom. You never short in the bottom a company with real catalysts.
News 
Market Data 
Discover 
AI
